SDIC Venture Capital

SDIC Venture Capital Co., Ltd. (SDICVC) is a Beijing-based venture capital firm established in 2016 by the State Development and Investment Corporation. Operating under a market-driven governance structure, SDICVC focuses on the marketization and industrialization of scientific and technological advancements in China. The firm emphasizes an investment strategy that aligns with national innovation goals and the transformation of technological achievements. With additional operations in Shanghai, SDICVC manages multiple funds, amassing total assets of RMB 14 billion. The company aims to foster synergy among government, society, and market forces while positioning itself as a reliable and influential partner in the venture capital landscape. Through its expertise, SDICVC diligently works to implement national development strategies and achieve both policy alignment and investment returns.

Zhuoxi Chen

VP

Zhi Xiao

Managing Partner

178 past transactions

FutureFab.AI

Series A in 2025
Zhixian Future is a provider of engineering intelligent system solutions driven by multi-modal large models, serving more than 180 benchmark semiconductor customers.

Yijin New Energy

Series C in 2025
Yijin New Energy focuses on developing and making lithium battery materials and new battery technologies.

Ouye Semiconductor

Series B in 2025
Ouyeel Semiconductor is a manufacturer of SoC chips. They offer smart car chips and solutions for automakers, enabling customers to reduce costs and time to develop new products and features.

Leadrive

Series E in 2025
LEADRIVE is a technology company specializing in the research, development, production, and sales of drive solutions for new energy vehicles, as well as high-performance power semiconductor modules. The company designs and manufactures advanced motor controllers and proprietary power modules that have been adopted by over ten leading automotive manufacturers and Tier-1 suppliers for mass production. LEADRIVE is also engaged in enhancing the localization of power semiconductor modules, with ongoing certification processes for silicon carbide modules and electronic controls. Additionally, the company invests in innovative energy solutions, including wind, solar, and energy storage systems. In collaboration with Rohm Semiconductor from Japan, LEADRIVE has established a joint laboratory to develop various silicon carbide modules, focusing on improving efficiency through comprehensive simulation, testing, and development processes that span from device-level to vehicle-level applications.

Cholesgen Pharmaceutical

Series A in 2025
Cholesgen is a biopharmaceutical company focused on developing innovative drugs for metabolic diseases and conditions related to tumor treatment. The company employs a comprehensive approach in its research and development processes, utilizing advanced technologies such as a reporter gene screening system, a protein-small molecule interaction system, and in vitro drug efficacy tests. These systems are based on the regulation mechanisms of target functions, allowing Cholesgen to create an independent platform for biochemical and cellular testing. This integrated methodology enables the company to optimize drug development efficiently and provide effective solutions to the medical industry. By concentrating on new disease targets informed by biochemistry, disease biology, and medicinal chemistry, Cholesgen aims to contribute significantly to advancements in drug therapies.

Kemi Biotech

Seed Round in 2025
Kemi Biotech is a preclinical immunotherapy product development company .

Qingke Jiahe

Series B in 2025
Qingke Jiahe manufactures semiconductor liquid pipelines, precision instrument systems, and other semiconductor equipment core components.

Zhejiang Xinglaihe

Venture Round in 2025
Zhejiang Xinglaihe is a modern agricultural machinery manufacturing company. It is committed to the research and development, manufacturing, and sale of high-speed rice transplanters, tractors, diesel engines, and other agricultural machinery.

Juli Automation Equipment

Private Equity Round in 2025
Juli Automation specializes in the development and manufacturing of electric vehicle (EV) components, focusing on flat wire motor technology. The company offers comprehensive solutions for motor winding and assembly, catering to the needs of international automotive OEMs. With a commitment to innovation, Juli Automation has achieved milestones such as delivering China's first automated EV motor stator line equipped with hairpin technology. This technology streamlines the complete winding process, enhancing the efficiency of EV motor production. Juli Automation also engages in research and development to advance new energy vehicle motor manufacturing, contributing to the growth of the EV industry globally.

BOPIXEL

Series A in 2024
BoPixel specializes in providing core components and system solutions for vision inspection and measurement, catering to various industries such as automotive, logistics, food, and pharmaceuticals. The company manufactures industrial cameras and digital light processing (DLP) projectors, which are essential for high-performance machine vision applications. BoPixel's products are widely utilized in sectors including semiconductors, new energy, and consumer electronics. By focusing on advancing machine vision technology, BoPixel aims to enhance inspection and measurement processes across diverse applications.

Unisic Technology

Series B in 2024
Unisic specializes in the design and manufacturing of silicon carbide core power components and semiconductor modules. The company develops a range of products utilizing third-generation silicon carbide materials, including power modules and driver circuits. Unisic's technology finds applications across various sectors, such as aviation, new energy power generation, high-end medical care, oil exploration, lighting, new energy vehicles, and data centers. By focusing on customized application solutions, Unisic aims to enhance the performance and efficiency of power systems in these critical fields.

Affinity

Series B in 2024
Affinity Biomedical Technology is a clinical biopharmaceutical company focusing on the development of global innovative anticancer drugs.

Ouye Semiconductor

Series B in 2024
Ouyeel Semiconductor is a manufacturer of SoC chips. They offer smart car chips and solutions for automakers, enabling customers to reduce costs and time to develop new products and features.

Xijia Precision

Venture Round in 2024
Xijia Precision provides polymer elastomers and high-functional plastic components.

Qiyuan Gas

Series C in 2024
Qiyuan Gas is an electronic gas company that offers xenon, krypton, helium, ultra-pure oxygen, carbon dioxide, and other items. It also offers high-end gas system solutions to semiconductor, flat panel display, aerospace, medical, and other industries.

Shanghai Lixin

Series B in 2024
Lixin specializes in the research and development of full-process tools for the industry.

Kaihong Digital

Series A in 2024
Kaihong Digital is an IoT operating system developer which focuses on developing IoT operating systems. The company's business model combines AloT operating system consultancy, R&D, customisation, delivery, and after-sales services to provide users with pan-intelligent terminal operating system technology and products.

Weikang Bio

Venture Round in 2024
Weikang Bio is a medical research company that engages in the development, production, and product service of probiotics and derivatives.

MoonBiotech

Series C in 2024
MoonBiotech is a biotechnology company focused on the commercialization of microbial resources.

Dachao Carbon Energy

Series B in 2024
Dachao Carbon Energy is an energy-tech company that specializes in the R&D, production, and sales of advanced carbon-based materials.

Noding Intelligence

Series B in 2024
Noding Intelligence is a pan-semiconductor testing equipment R&D and manufacturing company.

Mitro Biotech

Venture Round in 2024
Mitro Biotech is a domestic molecular imaging medical research and development outsourcing enterprise that specializes in contract research services aimed at shortening the drug development cycle and minimizing the risk of failure. The company offers a comprehensive suite of solutions for both domestic and international pharmaceutical companies and research institutions. Its services encompass drug screening, biodistribution studies, pharmacokinetic research, and pharmacodynamic evaluation, thereby facilitating the efficient introduction of new drugs to the market. By providing these essential services, Mitro Biotech enables pharmaceutical developers to expedite the transition of their products from the research phase to clinical trials and eventual market launch.

Xunlian Technology

Series B in 2024
Xunlian Technology is a manufacturer of measuring, control, communication, and navigation devices. Xunlian Technology provides measurement and control communication equipment and services for drones, satellites, rockets, and so on. Satellite navigation core electrical equipment.

Taihe Petrochemical

Venture Round in 2024
Taihe Petrochemical is a fluid control, industrial process solutions, and fluid technology consulting company that provides research and development, design, production, sales, and technical services for valves, pipe fittings, and other products.

HQ-Nano Integrated Circuit

Series A in 2024
HQ-Nano is an integrated circuit analysis and testing service platform that focuses on the development of high-end chip analysis technology and testing services.

Guangduo Micro-Nano Technology

Series B in 2024
Guangduo Micro-Nano Technology is dedicated to nanoimprint equipment and technology research and development as well as industrial promotion and application. It has created and manufactured a wide range of nanoimprint equipment, supporting processes, and consumables, and has successfully launched a completely automated system.The industrialization of mass-produced nanoimprint equipment has resulted in the industrial replacement of stepper lithography machines in the LED sector.

Join Silicon

Series B in 2024
JoinSilicon specializes in providing customized solutions for the semiconductor industry, focusing on chip custom design, system and embedded software design and verification, and integrated circuit package design. The company offers a comprehensive range of services, including simulation and testing, chip design services, and one-stop ASIC design solutions. By transforming application software into transistor-level layouts, JoinSilicon supports clients across various sectors, such as server and computing, automotive, Internet of Things (IoT), and networking. Their extensive experience in co-developing hardware and software enables clients to effectively translate their innovative ideas into tangible products.

AOSSCI

Venture Round in 2023
AOSSCI specializes in the development of unmanned aerial vehicles (UAV) and associated systems, including flight control systems and ground stations. The company offers a range of products, such as high-performance all-electric drones and integrated flight simulation platforms designed for various industrial applications. AOSSCI's UAV solutions are utilized in sectors such as land surveying, public safety, power line inspection, resource exploration, and environmental protection, both domestically and internationally. By focusing on advanced technology, AOSSCI aims to enhance operational capabilities across industries including oil exploration, landscape mapping, and smart urban management.

AlpsenTek

Series B in 2023
AlpsenTek is a high-tech company focused on the research and development of machine vision sensors and algorithms. The company has created an innovative machine vision imager featuring a unique pixel structure, along with a comprehensive solution that encompasses modules, algorithms, and systems. Drawing on extensive expertise in vision sensors and imaging signal processing, AlpsenTek's products have diverse applications across various sectors, including autopilot technologies, robotics, consumer electronics, surveillance, and industrial monitoring. Additionally, the company develops hybrid biomimetic vision chips, which enhance its integrated machine vision solutions for use in smartphones, motion cameras, autonomous driving, and virtual reality systems.

Bintie Biotechnology

Series A in 2023
Bintie Biotechnology is a pioneering biomedical technology enterprise in the clinical stage. Its primary products are novel immune cell formulations intended to target solid tumors.

Bangxin Semiconductor

Series B in 2023
Bangxin Semiconductor is dedicated to delivering cost-effective semiconductor equipment for the integrated circuit and pan-semiconductor sectors. The company focuses on four primary fields: compound semiconductors, integrated circuits, packaging and testing, and panel industries.

Northern Yiheng

Series B in 2023
Northern Yiheng is a producer of composite insulation materials made of semiconductor graphite fiber.

Century Kangtai

Series B in 2023
Century Kangtai is a Class III medical device manufacturer that combines production, research and development, and sales. Century Kangtai is a collagen material developer and ophthalmic clinical trial company. Its primary business is the research and development, production, and marketing of ocular implant devices, as well as the provision of after-sales services to consumers. It has computer numerical control air suspension and uses laser navigation technology and laser interference. Products that use measurement technology include integrated posterior chamber intraocular lenses, ocular fixation rings, and collagen sponges.

Guohua Technology

Venture Round in 2023
Guohua Technology specializes on ceramic material research and development. It is a company that specializes in microwave ceramic functional materials. It is a limited liability corporation that produces microwave communication devices and useful ceramic materials.

Canton Biologics

Series C in 2023
Canton Biologics is a contract development and manufacturing organization based in China, specializing in the research and development of biologic drugs. The company offers a range of services to biopharmaceutical companies, including the development and production of biomacromolecule drugs such as monoclonal antibodies, double antibodies, fusion proteins, and recombinant proteins. Canton Biologics supports both clinical and commercial production, catering to the needs of the biopharma sector through its expertise in biologic drug development. An online inquiry form is available on the company’s website for potential clients seeking their services.

Shengqiang Technology

Series B in 2023
Shengqiang Technology is an autonomous, innovative high-tech firm that combines R&D, manufacturing, and commercialization. It has adhered to its development strategy of being a leader in pathology digitalization, a creator of pathology information, an integrator of pathology intelligence, and an advocate for functional pathology from its inception.

Jinfang Pharmaceutical

Venture Round in 2023
Jinfang Pharmaceutical is focused on R&D and drug development from small molecule drug pipelines to diversified cutting-edge therapies.

ATOMsci

Series A in 2023
ATOMsci is a manufacturer of optoelectronic equipment that sells Raman spectrometers, photodetectors, lasers, and laser applications.

Fullcryo

Series C in 2023
Fullcryo provides solutions for helium extraction from natural gas, hydrogen liquefaction, and liquefied hydrogen storage.

Dehui Electronics

Venture Round in 2023
Dehui Electronics develops, manufactures, and sells high-performance electronic ceramics and related electronic components.

Time Speed

Venture Round in 2023
Time Speed ​​is a radio frequency integrated circuit developer, which can provide monolithic microwave integrated circuits, radio frequency integrated circuits, gallium arsenide gallium nitride power amplifier chips, low noise amplifier chips, and radio frequency front-end module chips for users in the 4G/5G communications market. And other products.

Yanming Biology

Series A in 2023
Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors.

Hithium Energy Storage

Series C in 2023
Hithium Energy Storage is a technology enterprise that focuses on the research, development, production, and sales of lithium-ion battery core materials and lithium iron phosphate (LFP) energy storage batteries and systems. The company aims to provide safe, efficient, clean, and sustainable energy storage solutions for its clients. Hithium has made significant advancements in battery safety and longevity, supported by four research and development centers and multiple intelligent production facilities. Through its innovations, Hithium is positioned to address the growing demand for reliable energy storage in various applications.

Sinotau

Series E in 2023
SinoTau is a comprehensive solution provider focused on both generic and innovative pharmaceuticals. The company specializes in the early development of antibody biopharmaceuticals and conducts research on a range of medications aimed at treating cancers, neurological disorders, and autoimmune diseases. With expertise in medicinal chemical synthesis, generic drug analysis, and pharmaceutical preparations, SinoTau supports the biotechnology industry through targeted drug development. Their work is underpinned by advanced diagnostic technologies and monoclonal antibody innovations, positioning them as a key player in the fields of cardiovascular health, neurodegeneration, and oncology.

Chenyao Technology

Seed Round in 2023
Chenyao Technology is a high-tech company that provides mobile office security services.It is a service provider for the new infrastructure of mobile office security, providing a uniform security management platform and secure access services to all workers who use mobile smart terminals in the new era.

Huaxun Semiconductor

Venture Round in 2023
Huaxun Semiconductor is a high-tech firm specialized in R&D, production, and distribution of essential materials for advanced integrated circuit packaging.The company focuses on providing system solutions and key materials for ultra-thin wafer processing and holding, ultra-thin device manufacturing, three-dimensional stack packaging, flexible display, conductive interconnection, and other fields, guided by the lightness, thinness, and shortness of integrated circuits.

HongHu Semiconductor

Series A in 2023
Honghu Semiconductor specializes in the research and development, as well as the production, of semiconductor equipment and silicon wafers. The company offers a diverse range of products, including Equipment Front End Modules, Automatic Wafer Transfer Machines, Vacuum Transfer Platforms, and various semiconductor precision components. Honghu Semiconductor provides advanced wafer automatic transfer technology, equipment solutions, and spare parts services, catering to large wafer production lines, chip manufacturers, semiconductor equipment manufacturers, and advanced packaging lines. Through its focus on localized production, the company aims to support the growing demands of the semiconductor industry.

VJTBio

Series C in 2023
VJTBio is a biopharmaceutical company specializing in high-end animal protein pharmaceuticals. The firm is dedicated to developing innovative treatments for animal health, with a particular emphasis on reproductive and immune health. By employing genetic recombination techniques, VJTBio focuses on creating biopharmaceuticals that enhance animal reproduction, prevent diseases, and promote overall pet health. In addition to its research and development efforts, the company is involved in the production and sales of these advanced treatments, offering clinical testing and technical services to the biopharmaceutical industry and medical professionals.

Eceyes Internet Financial

Series D in 2023
Eceyes Internet Financial is an insurance technology platform offering insurance and related products.

Life Biosciences

Series A in 2023
Life Biosciences specializes in providing a range of experimental animal resource services to support scientific research and the development of animal models. The company offers services such as blood biochemistry, routine blood testing, pathological staining, immunohistochemistry, fluorescence, molecular experiments, cell experiments, flow cytometry, x-ray irradiation, and nuclear magnetic resonance. Additionally, Life Biosciences supplies large animal disease models and various support services, including testing, imaging, foster care, and decontamination. By offering these comprehensive services, the company enables researchers in the scientific community to effectively utilize animal models for their studies and experiments.

Jianan Nongmu

Venture Round in 2023
Jianan Nongmu builds a new model of the agriculture and animal husbandry industry. The company is divided into three business units: digital supply chain financing, smart breeding, and smart logistics. Jianan Nongmu is dedicated to bringing back the agriculture and animal husbandry sectors of the economy through science and technology.

SinceVision

Series C in 2023
SinceVision is a manufacturing company that provides high-speed cameras, 3D laser profilers, sensors, and technical support services.

Surgerii Technology

Series C in 2023
Beijing Surgerii Technology Co., Ltd. specializes in the research, development, production, and sale of minimally invasive surgical robot systems in China. Founded in 2014 and based in Beijing, the company focuses on innovative technologies, particularly the next generation of flexible continuum robotic arms. Surgerii Technology aims to transform clinical practices through its single-hole and porous laparoscopic robot systems, enhancing the standard of care in minimally invasive surgeries. With a commitment to independent research and development, the company leverages its expertise in system design and integration to advance the medical equipment industry in China.

HongFuCheng

Venture Round in 2023
Hongfucheng specializes in the integration of research, development, manufacturing, and sales of advanced materials. The company produces innovative products such as electromagnetic interference (EMI) shielding materials, thermal interface materials, and wave-absorbing materials. These materials are designed for various applications, including mobile phones, new energy vehicles, and optical modules. By emphasizing research and development, Hongfucheng aims to provide clients with high-quality materials tailored to meet the demands of modern technology.

Zhishan Weixin Biotechnology

Series A in 2023
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas.

Spectron Technologies

Seed Round in 2023
Spectron Technologies specializes in communication platforms that enhance wireless connectivity, focusing on 5G products. The company provides holistic solutions for low-band and filtering, utilizing innovative filter-assisted technologies to serve its partners effectively. By leveraging scalable manufacturing processes, Spectron enables clients to adopt advanced operational strategies. Their offerings include filters and microsystems that support the development of cutting-edge communication systems, helping partners navigate the fast-paced marketplace with agility and insight.

Yike Polymers

Series B in 2023
Eco Polymer specializes in designing and manufacturing plastic tubes and parts. They provide products for polyethylene, polypropylene, polyamine, elastomers, fluoropolymers, and other various polymers. They serve the medical instrument, auto, electronics, fiber optics, semiconductor, chemical engineering, environment, and analytics industries.

Ruidiwei

Series C in 2023
Chengdu Ruidiwei Technology Co., Ltd. is a technology company based in Chengdu, China, established in 2014. The company focuses on the design, development, production, sales, and service of antennas, components, and chips that operate in microwave and millimeter-wave frequency bands. Ruidiwei aims to deliver innovative solutions in the telecommunications sector, contributing to advancements in wireless communication technology.

Yuze Semiconductor

Series B in 2023
Yuze Semiconductor is a research and development manufacturer of N-type solar monocrystalline silicon rods and silicon wafers. It was established in 2019 and is headquartered in China.

WITINMEM

Series B in 2023
Beijing Witinmem Technology Co., Ltd., founded in October 2017, specializes in artificial intelligence chips and system solutions utilizing processing-in-memory technology in NOR Flash memory. The company's innovative technology enables the execution of deep neural network inference directly within the NOR Flash memory, which significantly enhances performance, power efficiency, and accuracy. Witinmem's solutions are particularly applicable in speech and image processing, positioning the company at the forefront of low-cost, low-power AI chip development. By facilitating local AI processing independent of cloud resources, Witinmem is dedicated to advancing the integration of AI into everyday smart devices. The company is headquartered in Beijing, China.

KM Soft

Venture Round in 2022
KM Soft software is used in equipment manufacturing enterprises such as aviation, aerospace, aviation development, shipbuilding, electronics, automobiles, and construction machinery. Their software product center includes digital platforms, digital research and development, digital process, digital manufacturing, and 3D tool software.

AccuSilicon

Series F in 2022
Accusilicon Inc. is a manufacturer based in Santa Clara, California, specializing in TCXO IC chips. Founded in 2011, the company focuses on producing high-performance audiophile crystal oscillators and ultra-low phase jitter PLL and DIR modules, catering to audiophile applications. In addition to its audio technology, Accusilicon develops integrated circuit chips that enhance clock performance for mobile communications, improving data speeds for devices such as cell phones and high-speed Ethernet. This technology enables consumers to access faster internet connections at a lower cost, making Accusilicon a key player in the audio and mobile communication sectors.

Safe Medical Evaluation

Series D in 2022
Beijing Saifu Medical Research Institute Co., Ltd. relies on the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and the National Drug Safety Evaluation and Research Center of the State of Beijing to establish strategic partnerships with them to form a combination of technology, capital and enterprise operations. The core members of the company are researchers of the Institute of Materia Medica of the Chinese Academy of Sciences and researchers of the Academy of Military Medical Sciences. They have high scientific research and academic status in the fields of drug research and development and toxicology research, as well as rich drug development, GLP management and technical experience, and build and operate the platform. Provides strong talent and technical support.

Weishi Energy

Series B in 2022
Weishi Energy is a hydrogen fuel cell product research and development manufacturer, focusing on the market operation of hydrogen fuel cell technology, and is committed to promoting the low-carbon sustainable development of human energy. It is mainly engaged in the research and development, production and sales of hydrogen fuel cell products. At present, Weishi Energy has deployed five R&D centers in Shanghai, Baoding, Japan, Germany, and Canada. It has established a culturally diverse and technologically advanced R&D team, and strictly follows the V model development process to create vehicle-level fuel cell power systems and components. The company's main products include fuel cell engines, electric stacks, 35MPa/70MPa on-board hydrogen systems, bottle valves and pressure reducing valves, etc.

Grace Laser

Series C in 2022
Grace Laser Technology Co., Ltd., established in 2014 and headquartered in Beijing, China, specializes in the development of laser devices for various applications, including scientific research, industrial processing, and medical aesthetics. The company is committed to advancing the national laser industry and aims to establish a renowned domestic laser brand. Grace Laser possesses a comprehensive research and development, production, and quality management system, which enables it to deliver high-quality laser products and services to its clients.

Vivest

Series B in 2022
Vivest engages in R&D of emergency medical equipment.

Xindi Digital Engineering System

Venture Round in 2022
Xindi Digital Engineering System specializes in the development of commercial software products for computer-aided design (CAD), focusing on 3D technology. The company creates CAD content compatible with a variety of systems, including AutoCAD, SolidWorks, CATIA, UG, Pro/E, Inventor, Solid Edge, Geomagic, Maya, and 3D Studio Max. By providing these solutions, Xindi enables manufacturing enterprises to efficiently establish comprehensive digital product development and design systems.

GBase

Post in 2022
GBase is a Chinese company that specializes in developing database software solutions. It serves a diverse range of industries, including finance, telecommunications, government, energy, transportation, and national defense. By providing domestic-developed software, GBase enables enterprises to leverage robust database technologies tailored to their specific needs. The company's focus on serving critical sectors underscores its commitment to enhancing data management and operational efficiency for its clients.

Ningbo Testo Technology

Series A in 2022
Ningbo Testo Technology is a developer of back-end domestic EDA software and is committed to solving the electromagnetic compatibility and signal integrity problems caused by the increase in the operating frequency of integrated circuits in the post-Moore era, as well as dealing with new physical problems caused by chip process and material innovation. such as power integrity and thermal stability issues.

Jialichuang

Series B in 2022
JLCPCB is the globally leading PCB prototype enterprise and a high-tech manufacturer specializing in quick PCB prototype and small-batch PCB production. With over 14 years of experience in PCB manufacturing, JLCPCB has more than 800,000 customers all over the world, with over 18,000 online orders of PCB prototyping and small quantity PCB production per day. The annual production capacity is 600,000 sq.m. for various 1-layer, 2-layer or multi-layer PCBs. JLC is a professional PCB manufacturer featured of large scale, well equipment, strict management, and superior quality.

Linkingfresh.com

Series B in 2022
Linkingfresh.com is an online platform established in 2018 and based in Qingdao, China, that specializes in commodity trading and international fresh harvesting services. The company plays a pivotal role in the fresh industry by providing a comprehensive range of services, including international warehousing logistics, internet finance, and distribution processing. It connects major international manufacturers from over 20 countries, including the United States, Canada, and various European nations, to domestic producers. Linkingfresh.com offers thousands of high-quality fresh animal protein products, encompassing a diverse array of categories such as pork, beef, sheep, poultry, seafood, and processed meat products. The company is dedicated to streamlining the fresh industry supply chain and enhancing the accessibility of fresh produce to its clients.

Viiyong

Series B in 2022
Viiyong is a manufacturer based in Shenzhen, China, specializing in multi-layer ceramic chip capacitors. Established in 2001, the company emphasizes research and development to produce high-end capacitors tailored for the automotive electronics sector. By focusing on advanced technology and innovation, Viiyong aims to meet the specific needs of its customers in this industry.

Canwell Biotech

Series A in 2022
Canwell Biotech is an innovative drug research and development company that specializes in the creation of new anti-tumor therapies. The firm is committed to developing and commercializing First-in-Class and Best-in-Class immunotherapy drugs, aimed at enhancing treatment effectiveness for clients. Through its focused research efforts, Canwell Biotech seeks to advance the field of oncology by providing novel solutions that improve patient outcomes in cancer treatment.

Zhiyi Pharmaceutics

Series B in 2022
Zhiyi Pharmaceutics Inc. is a biopharmaceutical company founded in 2013 and headquartered in Guangzhou, China. The company specializes in the research and development of next-generation probiotics and live biotherapeutics, focusing on innovative products aimed at treating gastrointestinal disorders. Its portfolio includes products such as SK08, TP2, ZY19, and SK09, with SK08 poised to enter clinical trials. Zhiyi Pharmaceutics is committed to advancing the understanding of the human microbiome and its relationship with diseases, conducting extensive research on microbial cultures and the identification of new functional strains. The company has established a foundation of independent intellectual property rights in strain discovery and drug development, which underpins its innovative approach to biotherapeutics.

Dakang Medical

Series E in 2022
Dakang Medical operates a network of independent medical facilities specializing in blood purification services for kidney disease. The company focuses on providing advanced treatments such as hemodialysis, hemofiltration, and peritoneal dialysis, utilizing state-of-the-art medical technology. Dakang Medical emphasizes a patient-centered approach, aiming to create a warm and supportive environment to enhance the treatment experience for individuals suffering from nephropathy. In addition to its clinical services, Dakang Medical is involved in medical investment and the management of medical institutions, as well as offering brand operation services within the healthcare sector.

TBSTest

Venture Round in 2022
TBSTest Technology is a developer and manufacturer of automatic test equipment for integrated circuits, specializing in ultra-large-scale integrated circuit testing. Founded in 2017 and headquartered in Beijing, China, with additional offices in Xi’an and Shanghai, as well as Suwon, South Korea, the company provides a comprehensive range of products, including test boards, software solutions, and memory systems. TBSTest Technology also offers pre-sales and after-sales support for its equipment, accessories, and software systems, along with application development projects. The company serves a diverse clientele, including clients engaged in integrated circuit design and production, as well as scientific research institutions and educational establishments.

Ouye Semiconductor

Seed Round in 2022
Ouyeel Semiconductor is a manufacturer of SoC chips. They offer smart car chips and solutions for automakers, enabling customers to reduce costs and time to develop new products and features.

Yuansheng Pixel

Seed Round in 2022
Pixel offers AI, data algorithm, neural expansion that solves data technology problems and provides intelligent marketing solutions .

Weikaier Pharmaceutical Technology

Series A in 2022
Weikaier Pharmaceutical provides R&D of innovative drugs, transfer of generic drug technology, the production and sales of pharmaceuticals.

Beilai Bio

Series B in 2022
Beilai Bio is a clinical-stage biopharmaceutical company focused on the development of stem cell therapeutics for various diseases, particularly those with high unmet medical needs. Its established technology platforms allow them to produce clinical-grade "off-the-shelf" Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSC) from an unlimited supply of cord tissues that are traditionally regarded as medical waste.

Yihui Information

Series B in 2022
Yihui Information provides technical assistance and integrated hardware and software solutions. They also offer development kits, virtualization, cloud native that includes mission-critical cloud native, microservices architecture, container management services, and more.

G7

Private Equity Round in 2022
G7 is a provider and operator of fleet management systems that focuses on optimizing the transportation ecosystem in China. With an installation base of 800,000 cargo vehicles, the company utilizes proprietary hardware devices to gather critical data for logistics companies and drivers. Its platform enables businesses to monitor the location of trucks, track cargo status—including temperature and humidity—analyze fuel consumption, and record driver habits. By offering tools for route optimization and estimating departure and arrival times, G7 helps corporate clients and business owners enhance the efficiency of their transportation networks.

Ractigen Therapeutics

Series A in 2022
Ractigen Therapeutics is an early-stage pharmaceutical company focused on developing first-in-class therapies that aim to selectively restore the expression of therapeutic genes silenced in diseased cells. Utilizing a groundbreaking technology known as RNA activation (RNAa), which originated from research at the University of California San Francisco, Ractigen is working on a diverse pipeline of candidate medicines targeting various conditions with significant unmet medical needs. The company’s innovative approach addresses diseases related to inadequate gene expression, concentrating on key therapeutic areas such as central nervous system disorders, tumors, liver diseases, and ophthalmic conditions. By leveraging its unique technology and a portfolio of innovative patents, Ractigen strives to deliver effective treatment options to patients.

Air Touch

Series C in 2022
Air Touch is a Fvss dedicated to RF and microwave integrated circuit design companies, providing solutions for chips, modules, algorithms, software and even intelligent terminals. Become the world's leading supplier of microwave and millimeter wave radar chips and solutions. The technology is derived from the miniature millimeter wave short-range radar detector in the military industry. It has applied for more than 10 invention patents and has strong financial strength to support the company's sustainable development. The company dares to adopt first-class technical solutions to locate and develop world-class technology. Chip products.

Borui Jixin

Series D in 2022
Borui Jixin is a military-civilian integrated electronic information product supplier. The company focuses on the R&D and production of complete equipment and core chips in the fields of communications, radar, avionics and other fields. The products include monolithic drive amplifiers and parallel CNC attenuators. , Thin film power divider, etc.

MoonBiotech

Series C in 2021
MoonBiotech is a biotechnology company focused on the commercialization of microbial resources.

Gongda Satellite

Series A in 2021
Gongda Satellite is a commercial aerospace company that designs, manufactures on-orbit delivery commercial satellite products.

Jinyi New Material

Venture Round in 2021
Ginet New Material is a technology company providing R&D and production of inorganic non-metallic powder new material application solutions.

Time Speed

Series B in 2021
Time Speed ​​is a radio frequency integrated circuit developer, which can provide monolithic microwave integrated circuits, radio frequency integrated circuits, gallium arsenide gallium nitride power amplifier chips, low noise amplifier chips, and radio frequency front-end module chips for users in the 4G/5G communications market. And other products.

Sinomicro Medical

Series C in 2021
Sinomicro Medical is a medical device firm focused on the development of tumor ablation treatment with minimally invasive surgical robots.

Weishi Energy

Series A in 2021
Weishi Energy is a hydrogen fuel cell product research and development manufacturer, focusing on the market operation of hydrogen fuel cell technology, and is committed to promoting the low-carbon sustainable development of human energy. It is mainly engaged in the research and development, production and sales of hydrogen fuel cell products. At present, Weishi Energy has deployed five R&D centers in Shanghai, Baoding, Japan, Germany, and Canada. It has established a culturally diverse and technologically advanced R&D team, and strictly follows the V model development process to create vehicle-level fuel cell power systems and components. The company's main products include fuel cell engines, electric stacks, 35MPa/70MPa on-board hydrogen systems, bottle valves and pressure reducing valves, etc.

Vision Semiconductor Technology

Series A in 2021
The founding team of Vipas Semiconductor is composed of high-tech technical experts and market management experts from home and abroad. Relying on Nanjing University's independent innovation of vertical charge transfer imaging device (VPS) technology, it focuses on a new generation of new sensor imaging chip technology products. A high-tech company that develops and manufactures.

Immunochina

Series D in 2021
ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also provides medical technology development, medical research, medical trial development, and other services.

Guangdong Xinjuneng

Venture Round in 2021
Xinjuneng Semiconductor is a semiconductor device manufacturer integrating design, research and development, and production. It is mainly oriented to the new energy vehicle and power semiconductor application market, providing users with power semiconductor packaging, modules and other products.

Yingmai Medical

Series B in 2021
Yingmai Medical offers solutions for valve intervention, aortic and peripheral intervention, and neuromodulation. They are covering multiple innovative technology fields, such as structural heart disease treatment, pan-vascular disease treatment, nerve stimulation, and a brain-computer interface platform.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.